80 related articles for article (PubMed ID: 12806426)
1. Rho-kinase as a potential target for the treatment of erectile dysfunction.
Chitaley K; Webb RC; Mills TM
Drug News Perspect; 2001 Dec; 14(10):601-6. PubMed ID: 12806426
[TBL] [Abstract][Full Text] [Related]
2. RhoA/Rho-kinase: a novel player in the regulation of penile erection.
Chitaley K; Webb RC; Mills TM
Int J Impot Res; 2001 Apr; 13(2):67-72. PubMed ID: 11426341
[TBL] [Abstract][Full Text] [Related]
3. RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights.
Jin L; Burnett AL
Clin Sci (Lond); 2006 Feb; 110(2):153-65. PubMed ID: 16411892
[TBL] [Abstract][Full Text] [Related]
4. [Effects of RhoA/Rho-kinase in the regulation of penile erection].
Xia C; Jiang R
Zhonghua Nan Ke Xue; 2007 Jun; 13(6):546-9. PubMed ID: 17615983
[TBL] [Abstract][Full Text] [Related]
5. The ups and downs of Rho-kinase and penile erection: upstream regulators and downstream substrates of rho-kinase and their potential role in the erectile response.
Chitaley K; Webb RC; Mills TM
Int J Impot Res; 2003 Apr; 15(2):105-9. PubMed ID: 12789389
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats.
Wilkes N; White S; Stein P; Bernie J; Rajasekaran M
Int J Impot Res; 2004 Apr; 16(2):187-94. PubMed ID: 15073608
[TBL] [Abstract][Full Text] [Related]
7. Proerectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the rat penis.
Teixeira CE; Ying Z; Webb RC
J Pharmacol Exp Ther; 2005 Oct; 315(1):155-62. PubMed ID: 15976017
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between RhoA/Rho-kinase signaling pathway and penile erection].
Zhu PY; Jiang R
Zhonghua Nan Ke Xue; 2008 Feb; 14(2):155-8. PubMed ID: 18390182
[TBL] [Abstract][Full Text] [Related]
10. Y-27632 improves the erectile dysfunction with ageing in SD rats through adjusting the imbalance between nNo and the Rho-kinase pathways.
Gao BH; Zhao ST; Meng FW; Shi BK; Liu YQ; Xu ZS
Andrologia; 2007 Aug; 39(4):146-50. PubMed ID: 17683464
[TBL] [Abstract][Full Text] [Related]
11. Physiological regulation of penile arteries and veins.
Prieto D
Int J Impot Res; 2008; 20(1):17-29. PubMed ID: 17637789
[TBL] [Abstract][Full Text] [Related]
12. Topical application of a Rho-kinase inhibitor in rats causes penile erection.
Dai Y; Chitaley K; Webb RC; Lewis RW; Mills TM
Int J Impot Res; 2004 Jun; 16(3):294-8. PubMed ID: 14961052
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation.
Löhn M; Steioff K; Bleich M; Busch AE; Ivashchenko Y
Eur J Pharmacol; 2005 Jan; 507(1-3):179-86. PubMed ID: 15659308
[TBL] [Abstract][Full Text] [Related]
14. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
[TBL] [Abstract][Full Text] [Related]
15. Erection capability is potentiated by long-term sildenafil treatment: role of blood flow-induced endothelial nitric-oxide synthase phosphorylation.
Musicki B; Champion HC; Becker RE; Liu T; Kramer MF; Burnett AL
Mol Pharmacol; 2005 Jul; 68(1):226-32. PubMed ID: 15851653
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for erectile dysfunction in the US.
Selvin E; Burnett AL; Platz EA
Am J Med; 2007 Feb; 120(2):151-7. PubMed ID: 17275456
[TBL] [Abstract][Full Text] [Related]
17. Erectile dysfunction.
Wessells H; Joyce GF; Wise M; Wilt TJ
J Urol; 2007 May; 177(5):1675-81. PubMed ID: 17437781
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors and prevalence of erectile dysfunction amongst Icelandic men aged 45-75].
Geirsson G; Thornorgeirsson G; Guethmundsson O; Einarsson G
Laeknabladid; 2006; 92(7-8):533-7. PubMed ID: 16819001
[TBL] [Abstract][Full Text] [Related]
19. Erectile dysfunction.
Singh JC; Devasia A; Gnanaraj L; Chacko KN
Natl Med J India; 2005; 18(3):139-43. PubMed ID: 16130616
[TBL] [Abstract][Full Text] [Related]
20. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
